(Q33410398)

26 July 2017

title

Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations (English)

1 reference

single-nucleotide polymorphism

26 July 2017

main subject

1 reference

Hovav Nechushtan

1

1 reference

26 July 2017

Tamar Hamburger

2

1 reference

26 July 2017

Susan Mendelson

3

1 reference

26 July 2017

Luna Kadouri

4

1 reference

26 July 2017

Nir Sharon

5

1 reference

26 July 2017

Eli Pikarsky

6

1 reference

26 July 2017

Tamar Peretz

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

18 February 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

60

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

18 February 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Haplotype structure and selection of the MDM2 oncogene in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

MDM2 protein expression is a negative prognostic marker in breast carcinoma.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Mdm2 in growth signaling and cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.

14 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 SNP309 and cancer risk: a combined analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-60

MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2667534

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19226467

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19226467

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-9-60

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference